Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis-Reference-Cited by-同舟云学术

Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis

Published:2017-11 Issue:5 Volume:72 Page:660-664
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Bhindi Bimal,Frank Igor,Mason Ross J.,Tarrell Robert F.,Thapa Prabin,Cheville John C.,Costello Brian A.,Pagliaro Lance C.,Karnes R. Jeffrey,Thompson R. Houston,Tollefson Matthew K.,Boorjian Stephen A.

Publisher

Elsevier BV

Subject

Urology

Reference12 articles.

1. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data;Eur Urol,2005

2. International Collaboration of Trialists, et al. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. J Clin Oncol 2011;29:2171-7 http://dx.doi.org/10.1200/JCO.2010.32.3139.

3. Pathological T0 following radical cystectomy with or without neoadjuvant chemotherapy: a useful surrogate;Lavery;J Urol,2014

4. Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis;Petrelli;Eur Urol,2014

5. Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer;Zargar;Eur Urol,2015

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathologic and survival outcomes following radical cystectomy for “progressive” and “de novo” muscle-invasive bladder cancer: A meta-analysis stratified by neoadjuvant chemotherapy status;Urologic Oncology: Seminars and Original Investigations;2024-10

2. Clinical Upstaging After Neoadjuvant Chemotherapy Impacting Eligibility for Vaginal-sparing Cystectomy: Identifying Bladder Cancer Patients Who May Benefit From Interim Imaging;Urology;2024-09

3. Neoadjuvant Cisplatin-based Chemotherapy in Nonmetastatic Muscle-invasive Bladder Cancer: A Systematic Review and Pooled Meta-analysis to Determine the Preferred Regimen;Urology;2024-06

4. Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy;2024-05-02

5. Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer;JCO Precision Oncology;2024-04